Skip to main content
. 2016 Apr 14;22(14):3852–3859. doi: 10.3748/wjg.v22.i14.3852

Table 1.

Expression of integrin αvβ6 and MMP-9 and patient characteristics

Characteristic No. αvβ6
P value MMP-9
P value
Negative Positive Negative Positive
Age (yr)
< 60 51 33 18 31 20
> 60 75 49 26 0.942 42 33 0.593
Gender
Male 78 50 28 43 35
Female 48 32 16 0.769 30 18 0.416
Location
Upper 27 20 7 16 11
Middle 51 28 23 28 23
Lower 48 34 14 0.136 29 19 0.847
Lauren type
Intestinal 83 47 36 46 37
Diffuse 43 35 8 0.006 27 16 0.427
Differentiation
Well 19 15 4 6 13
Moderate 30 14 16 18 12
Poor 77 53 24 0.038 49 28 0.039
T stage
T1 14 10 4 3 11
T2 13 7 6 8 5
T3 18 10 8 14 4
T4 81 55 26 0.578 48 33 0.014
N stage
N0 37 26 11 18 19
N1 17 12 5 10 7
N2 26 10 16 11 15
N3 46 34 12 0.016 34 12 0.033
M stage
M0 124 81 43 73 51
M1 2 1 1 0.652 0 2 0.094
TNM stage
I 12 4 8 3 9
II 42 36 6 22 20
III 70 41 29 48 22
IV 2 1 1 0.002 0 2 0.008

MMP-9: Matrix metalloproteinase 9.